4 days ago · INDIANAPOLIS, Feb. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial guidance. "2024 was a highly successful year for Lilly," said David A. Ricks, Lilly's chair and CEO."We had major data readouts for tirzepatide in treating chronic disease associated with obesity, invested billions more in ...

5 days ago · INDIANAPOLIS, Feb. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial guidance. "2024 was a ...

5 days ago · growth: 45% in Q4 vs. prior year . Lilly share of market increased 3ppts in Q4 2024 and 5ppts vs. 2023 year-end. Lilly market leader in new prescriptions

The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.

4 days ago · INDIANAPOLIS, Feb. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial guidance. "2024 was a highly successful year for Lilly," said David A. Ricks , …

4 days ago · Eli Lilly and Co reported a 32% increase in full-year revenue for 2024, exceeding guidance by $4 billion. The company achieved a 45% revenue growth in Q4 2024, driven by strong performance of new ...

5 days ago · Eli Lilly (LLY) reported strong Q4 2024 financial results with revenue increasing 45% to $13.53 billion, primarily driven by Mounjaro and Zepbound sales.Q4 EPS grew 102% to $4.88 on a reported basis and 114% to $5.32 on a non-GAAP basis. The company received FDA approval for Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity and Omvoh for Crohn's disease.

4 days ago · Global pharmaceutical company Eli Lilly (NYSE:LLY) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 44.7% year on year to $13.53 billion. ... Eli Lilly (LLY) Q4 CY2024 ...

5 days ago · INDIANAPOLIS, Feb. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth quarter of 2024 and detailed 2025 financial guidance. "2024 was a ...

4 days ago · Eli Lilly and Company announced their Q4 2024 earnings on 2/6/2025. View LLY's earnings results, and press release at MarketBeat.